COVID 19 therapies and anti-cancer drugs: A systematic review of recent literature

Viral Infections, Non-HIV

Cancer associates with risk and severe events of COVID-19: A systematic review and meta-analysis

Int J Cancer.

Tian Y, Qiu X, Wang C, Zhao J, Jiang X, Niu W, Huang J, Zhang F

doi: 10.1002/ijc.33213.

Viral Infections, Non-HIV

Non-steroidal anti-inflammatory drugs in management of COVID-19; A systematic review on current evidence

Int J Clin Pract.

Yousefifard M, Zali A, Zarghi A, Madani Neishaboori A, Hosseini M, Safari S

doi: 10.1111/ijcp.13557.

Viral Infections, Non-HIV

The risk and prognosis of COVID-19 infection in cancer patients: A systematic review and meta-analysis

Hematol Oncol Stem Cell Ther.

ElGohary GM, Hashmi S, Styczynski J, Kharfan-Dabaja MA, Alblooshi RM, de la Cámara R, Mohmed S, Alshaibani A, Cesaro S, Abd El-Aziz N, Almaghrabi R, Gergis U, Majhail NS, El-Gohary Y, Chemaly RF, Aljurf M, El Fakih R

doi: 10.1016/j.hemonc.2020.07.005.

Viral Infections, Non-HIV

Potential effective treatment for COVID-19: systematic review and meta-analysis of the severe infectious disease with convalescent plasma therapy

Int J Infect Dis.

Sun M, Xu Y, He H, Zhang L, Wang X, Qiu Q, Sun C, Guo Y, Qiu S, Ma K

doi: 10.1016/j.ijid.2020.06.107.

Viral Infections, Non-HIV

Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol

Eur Heart J Acute Cardiovasc Care.

Naksuk N, Lazar S, Peeraphatdit TB

doi: 10.1177/2048872620922784.

Viral Infections, Non-HIV

Convalescent plasma transfusion for the treatment of COVID-19: Systematic review

J Med Virol.

Rajendran K, Krishnasamy N, Rangarajan J, Rathinam J, Natarajan M, Ramachandran A

doi: 10.1002/jmv.25961.

Viral Infections, Non-HIV

Considerations for interactions of drugs used for the treatment of COVID-19 with anti-cancer treatments

Crit Rev Oncol Hematol.

Jafari A, Dadkhahfar S, Perseh S

doi: 10.1016/j.critrevonc.2020.102982.

Viral Infections, Non-HIV

A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in Coronavirus Disease-19 (COVID-19)

Int J Rheum Dis.

Shah S, Das S, Jain A, Misra DP, Negi VS

doi: 10.1111/1756-185X.13842.

Viral Infections, Non-HIV

Obesity aggravates COVID-19: a systematic review and meta-analysis

J Med Virol.

Yang J, Hu J, Zhu C

doi: 10.1002/jmv.26237.

Related content

Cancer associates with risk and severe events of COVID-19: A systematic review and meta-analysis

Non-steroidal anti-inflammatory drugs in management of COVID-19; A systematic review on current evidence

The risk and prognosis of COVID-19 infection in cancer patients: A systematic review and meta-analysis

Potential effective treatment for COVID-19: systematic review and meta-analysis of the severe infectious disease with convalescent plasma therapy

Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol

Convalescent plasma transfusion for the treatment of COVID-19: Systematic review

Considerations for interactions of drugs used for the treatment of COVID-19 with anti-cancer treatments

A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in Coronavirus Disease-19 (COVID-19)

Obesity aggravates COVID-19: a systematic review and meta-analysis